• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Hazardous Reagent Substitution: A Pharmaceutical Perspective

Hazardous Reagent Substitution: A Pharmaceutical Perspective

9781782620501
938,70 zł
844,83 zł Zniżka 93,87 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 844,83 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
In recent years, a significant amount of progress has been made using green chemistry in the synthesis of synthetically useful compounds and molecules by replacing hazardous chemicals with greener alternatives. However, there is still room for improvement, especially in the pharmaceutical sector where new drugs are being formulated. This book examines green approaches to overcoming hazardous organic transformations. Summarizing recent developments, the book features a detailed description of some of the high impact active pharmaceutical ingredients that have been developed considering green chemistry approaches. It explores the design, engineering and process development and the calculations to account for waste. The book includes strategies to further advance green approaches in the development of generic pharmaceutical industries and features novel, innovative approaches that promote waste-free organic synthesis. This book is of interest to industrialists working in pharmaceuticals and researchers working in green chemistry.
Szczegóły produktu
77351
9781782620501
9781782620501

Opis

Rok wydania
2017
Numer wydania
1
Oprawa
twarda
Liczba stron
194
Wymiary (mm)
156.00 x 234.00
Waga (g)
461
  • Introduction to Hazardous Reagent Substitution in the Pharmaceutical Industry; Recyclability of Reagents; Recoverable Polymer-supported DMAP Derivatives; Synthesis of Atorvastatin; Synthesis of Raloxifene; Synthesis of Montelukast; Development of a Safe, Scalable, Azide-free Synthesis of 1-Aryl-1H-tetrazoles Using Diformylhydrazine; New Directions from Academia
Komentarze (0)